[Embolization of splenic artery aneurysms: Treatment of choice. About a case and review of the literature].

Embolisation des anévrysmes de l’artère splénique : traitement de choix. À propos d’un cas et revue de la littérature.

Journal

Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 17 08 2020
accepted: 04 11 2020
pubmed: 4 12 2020
medline: 27 4 2022
entrez: 3 12 2020
Statut: ppublish

Résumé

Splenic artery aneurysms constitute 60% of digestive artery aneurysms. They are often discovered incidentally and by imaging. Currently, endovascular treatment is considered the first-line treatment, as it is less invasive with less morbidity and mortality than surgery. An aggressive approach in their management is certainly justified because the overall mortality of ruptured splenic aneurysms is 25%. False splenic aneurysms have a greater potential for rupture than true aneurysms because they grow faster. Endovascular treatment is generally indicated for aneurysms larger than 2cm or with an increase in size of more than 0.5cm/year. Embolization is rarely associated with an infarction of the spleen due to the good supply of short gastric vessels. Embolization is performed using different materials including coils, which can be used alone or with other embolic agents. Post-embolization syndrome can be seen with persistent pain, fever and other systemic symptoms. Endovascular treatment compared to open surgery is associated with better quality of life and appears to be the most cost-effective strategy. Endovascular treatment and especially coil embolization are starting to be the standard treatment. Surgical and laparoscopic treatment are reserved for ruptured aneurysms which are burdened with significant mortality, especially in pregnant women. We report the case of a 66-year-old female patient in whom a splenic artery aneurysm was discovered incidentally during an ultrasound for an ovarian cyst.

Identifiants

pubmed: 33267947
pii: S0003-3928(20)30190-6
doi: 10.1016/j.ancard.2020.11.002
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

108-111

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Y Tijani (Y)

Département de chirurgie vasculaire et endovasculaire, Hôpital Universitaire International Cheikh Khalifa Ben Zaid, Faculté de Médecine, Université Mohammed VI des sciences de santé (UM6SS), Casablanca, Maroc. Electronic address: dr.yousseftijani@gmail.com.

O Zahdi (O)

Service de chirurgie vasculaire, Centre hospitalo-universitaire Ibn Sina, Université Mohammed V, Rabat, Maroc.

M Hormat-Allah (M)

Service de chirurgie vasculaire, Centre hospitalo-universitaire Ibn Sina, Université Mohammed V, Rabat, Maroc.

Y Zaid (Y)

Faculty of Sciences, Mohammed V University, Rabat, Maroc; Research Center of Abulcasis University of Health Sciences, Rabat, Maroc.

M Raux (M)

Department of vascular and endovascular surgery, hôpital Paris St Joseph, Paris, France.

Y Gouëffic (Y)

Department of vascular and endovascular surgery, hôpital Paris St Joseph, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH